| Prashant Sharma, MD | |
|
1281 N 600 E, Logan, UT 84341-6988 | |
| (801) 408-1262 | |
| Not Available |
| Full Name | Prashant Sharma |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 20 Years |
| Location | 1281 N 600 E, Logan, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548430663 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lds Hospital | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Westburg BV today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in the Benelux region.
The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer.
Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Westburg BV today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in the Benelux region.
The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer.
Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prashant Sharma, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: () - | Prashant Sharma, MD 1281 N 600 E, Logan, UT 84341-6988 Ph: (801) 408-1262 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Westburg BV today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in the Benelux region.
The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer.
Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction.
› Verified 5 days ago
Rudolf Otrusinik, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1300 N 500 E, Suite 320, Logan, UT 84341 Phone: 435-755-8200 Fax: 435-752-6094 | |
Harold Vonk, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-1980 | |
Robert M Nash, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1980 | |
Agnieszka M Szpunar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1980 | |
Dr. Stephen J Ferney, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-752-1693 Fax: 435-792-1692 | |
Dr. Stephen Christensen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 W 1250 North Suite 8a, Logan, UT 84341 Phone: 385-244-4020 Fax: 385-244-4022 | |
Ali Ben-jacob, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1281 North 600 East, Logan, UT 84341 Phone: 435-752-5999 Fax: 435-752-5551 |